CompletedNot Applicable

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

India675 participantsStarted 2023-03-24

Plain-language summary

The purpose of this study is to better understand the main barriers to earlier diagnosis and better management of MASLD/MASH patients and to understand the key barriers to adoption of guidelines. This study is a cross-sectional design, conducted across 5 countries in Europe- France, Germany, Spain, United Kingdom (UK), Italy. Study participants, Hepatologists and other metabolically focused healthcare providers (HCPs), will be recruited to complete a 15 minute self-administered online survey.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
✓. Male or female, age above or equal to 18 years at the time of signing informed consent.
✓. Is a physician
✓. Lives in UK, France, Germany, Italy or Spain
✓. Primary medical specialty is:
✓.a. Hepatology or 5.b. Gastroenterology or Internal Medicine with a subspecialty in Hepatology 6. In practice at least 3 years 7. Spends at least 50 percent of their time in an office/clinic setting 8. Spends at least 60 percent of their time in direct patient care 9. Sees at least 15 patients/month with MASH/MASLD
✓. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
✓. Male or female, age above or equal to 18 years at the time of signing informed consent.

Exclusion criteria

✕. Previous participation in this study. Participation is defined as having given informed consent in this study
✕. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
✕. Does not meet inclusion criteria requirements

What they're measuring

Unaided awareness

Timeframe: At the time of survey response (Day 1)

Aided awareness

Timeframe: At the time of survey response (Day 1)

Behaviours relative to diagnosing and managing MASLD

Timeframe: At the time of survey response (Day 1)

Use of current guidelines

Timeframe: At the time of survey response (Day 1)

Barriers in guideline adoption

Timeframe: At the time of survey response (Day 1)

Trial details

NCT IDNCT05765890

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-09-12

View on ClinicalTrials.gov More Non-alcoholic Steatohepatitis (MASH) trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
✓. Male or female, age above or equal to 18 years at the time of signing informed consent.
✓. Is a physician
✓. Lives in UK, France, Germany, Italy or Spain
✓. Primary medical specialty is:
✓.a. Hepatology or 5.b. Gastroenterology or Internal Medicine with a subspecialty in Hepatology 6. In practice at least 3 years 7. Spends at least 50 percent of their time in an office/clinic setting 8. Spends at least 60 percent of their time in direct patient care 9. Sees at least 15 patients/month with MASH/MASLD
✓. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
✓. Male or female, age above or equal to 18 years at the time of signing informed consent.

Exclusion criteria

✕. Previous participation in this study. Participation is defined as having given informed consent in this study
✕. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
✕. Does not meet inclusion criteria requirements

What they're measuring

Unaided awareness

Timeframe: At the time of survey response (Day 1)

Aided awareness

Timeframe: At the time of survey response (Day 1)

Behaviours relative to diagnosing and managing MASLD

Timeframe: At the time of survey response (Day 1)

Use of current guidelines

Timeframe: At the time of survey response (Day 1)

Barriers in guideline adoption

Timeframe: At the time of survey response (Day 1)